![](https://medcitynews.com/wp-content/themes/medcitynews/dist/images/mcn.png)
Harvard spinout XTuit gets $4M to target the tumor microenvironment
Polaris Partners-backed XTuit Pharmaceuticals, a cancer-centric biotech that targets therapeutics in the tumor microenvironment, just raised $4 million from three investors – and, according to a regulatory filing, is planning to bring in $6 more. The company was founded in 2011 by Harvard professor Rakesh Jain, MIT chemical engineering professor Bob Langer and Polaris partner Alan […]